Ligand-directed differences in the amount of pepcapable of eliciting both types of immunity to the a2(IV) tide presented on a specific APC subset could influence chain, aa 675-686 (14). Truncation of the C-terminus the functional outcome of any given immune response.
INTRODUCTION age and sex matched for quantitative analyses.
A role for the major histocompatibility complex Peptides (MHC) in directing immunity toward cell-mediated versus humoral response pathways is suggested by Synthetic peptides used in these studies were synstudies in experimental animals (1) (2) (3) (4) (5) (6) and by certain thesized and purified by Research Genetics, Inc. human disease states (7) (8) (9) (10) (11) . In the mouse immune (Huntsville, AL) and purity confirmed to ú95% homoresponse to human type-IV collagen, mutually exclu-geneity by mass spectrometry (MassSpec Lab, Universive Th-response patterns are observed (2) . Recall CD4 sity of Kansas, Lawrence, KS). The structure of the T cell proliferation and IL2 and IFN-g production are minimal collagen-IV peptide (12mer) and its otherwise associated with I-A s genotype mice, whereas I-A non-s identical C-truncated derivative (11mer) have been strains display recall CD4 T cell help for hapten-spe-previously reported (single letter amino acid code):
12mer, EAIQPGCIGGPK; 11mer, EAIQPGCIGGP (14). Peptides were biotinylated as previously described 1 To whom correspondence should be addressed at Division of Biolwith a short-chain NHS-biotin (N-hydroxysuccinimi- 
Generation of CD4 Th Clones
resulting suspension, in HBSS, was fractionated with lymphocyte separation medium (LSM) from Organon CD4 T cell clones specific for the collagen-IV minimal Teknika (Rockville, MD). For depletion of specific cell peptide were prepared from I-A s and I-A b congenic mice types, the LSM-prep was incubated with either unconas previously described (14). The clones reported have jugated anti-B220 (clone RA3-6B2, PharMingen), or been in culture for 1-2 years, have been subcloned at anti-CD4 (clone GK1.5), CD8 (clone TIB105), both from least twice by limiting dilution, and were analyzed for ATCC (Rockville, MD). . We found that the mini-DAP.3, have also been described (15). We confirmed mal collagen-IV peptide capable of eliciting Th1 immuthat the transfectants express the B7-1 costimulatory nity in I-A s mice and Th2 immunity in I-A b mice was ligand (18) and were found to be B7-2 0 (data not presented at a significantly higher density on splenic shown).
APC of the I-A s genotype (14). In order to determine if single TCR-bearing populations responded to such a Peptide Presentation Density Analysis by Flow ligand density difference, we derived several CD4 Th Cytometry clones with different TCR from each I-A genotype. As illustrated by the data in Fig. 1 , there is a striking Spleen cell suspensions from normal unimmunized mice were prepared from groups of three animals with conservation in low peptide dose activation in I-A s -derived clones which is not found among similarly derived the ground-glass ends of sterile microscope slides. The cell marker, B220 (CD45R), and, as expected, peptide density increases on these cells with increasing peptide dose. Note that peptide density on these B cells is significantly different between I-A s and I-A b genotypes (compare Fig. 2 , left to right). As summarized in cells by MiniMACS technology (Materials and Methods), and these B220 0 cells were compared for B7-2 and peptide density to the untreated populations (Fig. 3 , compare right to left panels). These results confirm clones from the congenic I-A b strain. The finding that that the high peptide presenters are B cells because several different TCR display this dose discrepancy anti-B220 treatment shows a ú97% depletion of these suggests that TCR affinity is not the factor driving the 16) . In order to determine if this specific polymorphism could be responsible for the unique pepTo determine if a particular type of APC was responsible for I-A associated differences in the density of tide presentation properties of the I-A s genotype, we analyzed the dose-response curves of nominally I-A b -peptide presented, we used a combination of multicolor flow cytometry and mAb-negative selection techniques. restricted Th clones presented with the collagen-IV minimal peptide on mutant (position-70 glutamine) As is shown in Fig. 2 , three-color analysis of the freshly isolated normal cells that bind high density of the pep-versus wild-type (position-70 arginine) I-A transfected fibroblast lines. As is shown in Fig. 5 (top experiment) , tide reveals that the cells are positive for the pan B we found a clear 1-2 log preference for Th proliferation lier work on the presentation densities of the 12mer on the s-like mutant fibroblasts. Thus, similar to the versus 11mer peptides, where we showed that the situation in Fig. 1 , s-like I-A molecules present the 12mer, but not the 11mer can achieve high-density prepeptide more efficiently to single, and different TCR-sentation on I-A s APC (14). Moreover, since the 12mer, bearing cells. In this case, the same TCR-bearing popu-but not the 11mer, elicits exclusive Th1-like immunity lation responds at a 1-2 log lower peptide dose on the s-in vivo (14), these data on Ia-transfected fibroblasts like APC. We wondered if the mutation effects a direct confirm that the density of the peptide presented on contact between the TCR and the MHC molecule, a MHC class II molecules in vitro correlates with the in contact between the TCR and the peptide, or depends vivo Th response pattern. Finally, since the B63 Th1 on the density of peptide presented. We used our previ-clone does not recognize the effects of peptide positionous knowledge about presentation and Th responses 12 lysine on wild-type I-A molecules, (compare FT7.1 to a C-truncated derivative of the minimal 12mer to and splenic APC curves for the 12mer versus 11mer; investigate this issue. tide (14). Thus, it seems that either ligand density drives the increased reactivity of the B63 clone or the As is demonstrated in Fig. 5 (bottom experiment) , it s-like MHC:peptide ligand more effectively contacts the is clear that the effect of the position-70 s-like substitu-TCR in a manner that requires peptide position 12. tion must involve the position-12 lysine of the peptide.
With regard to ligand density, this was a peptide-speWhen the C-terminal lysine is absent from the minimal cific effect because staining for total I-A levels showed peptide (right panel, 11mer), there is no augmentation similar levels on the transfectants and B cells exameffect of the s-like mutation on Th proliferation (see left panel 12mer control). This result mirrors our ear-ined (data not shown). While we cannot rule out confor- mutant MHC. In the bottom experiment, the s-like preference was found to require the 12mer peptide C-terminus, as the truncated 11mer peptide (right panel, 11mer) was similarly presented by both MHC molecules to the same TCR-bearing clone that shows an s-like preference with the 12mer (left panel, 12mer control).
mational effects on the peptide or MHC, on a quantitative basis, the 1-2 log shift in peptide presentation density could account for the 1-2 log shift in proliferation in the absence of altering the intrinsic affinity of the ligand for the TCR. An important question remains, however, with regard to why this in vitro effect of peptide-specific ligand density on B cells is associated with selective Th1-like immunity in vivo.
DISCUSSION
Focusing high ligand density to activated B lymphocytes might have been an expected aspect of a mechanism which selects for Th1-like immunity. Like dendritic cells, B cell blasts express ligand for costimulation via CD28/CTLA-4 (25) . Recent data showed that only slightly lower than dendritic cell presentation (22).
Three-color analysis was performed as previously described and the peptide binding cells counterstained with B7-1-PE (FL2). This is consistent with an effect of B cell antigen pre-sentation on recall T cell proliferation, in the absence
